Italy – Pharmaceutical products – Bando SDA FARMACI EMODERIVATI SOLUZIONI INFUSIONALI VACCINI E MEZZI DI CONTRASTO prima edizione
Opportunity Score
Confidence: 60%
Complexity: medium
1204 days
Deadline
supplies
Contract
Deep Portfolio Analysis
- Company fit score
- Missing certificates
- Eligibility blockers
- Bid / No-Bid recommendation
AI Analysis Summary
This tender is a Dynamic Purchasing System (DPS) for pharmaceutical products (blood-derived drugs, infusion solutions, vaccines, and contrast media) issued by PuntoZero s.c.a.r.l. on behalf of Italian healthcare entities. It is a restricted procedure with a single lot, valued at €3.5 billion, covering a 4-year period. The award is based solely on price. The tender is published in Italian, with submission required electronically via the provided platform. The deadline for submission is October 1, 2029. Key eligibility includes registration with professional/commercial registers and certifications for quality and environmental management.
Strengths
Documents available
Medium complexity
1204 days left
Risks
Restricted procedure — pre-qualification required
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
- DPS participation requires registration on the platform (Aura)
- Restricted procedure – only pre-selected suppliers may bid on specific contracts
- Submission must be electronic via Open portal
Buyer
Name
PuntoZero s.c.a.r.l.
Location
Perugia, ITA
Buyer profile
Identifier
02915750547
Lots (1)
Procurement of pharmaceutical products including blood-derived drugs, infusion solutions, vaccines, and contrast media.
Procurement Details
Publication
29 Sep 2025
Deadline
01 Oct 2029, 09:00
Procedure
restricted
Contract
supplies
Duration
1460 DAY
Language
ITA
Publication #
636806-2025
Classification
Performance: Italy
Documents (2)
Opportunity Score
Confidence: 60%
Complexity: medium
1204 days
Deadline
supplies
Contract
Deep Portfolio Analysis
- Company fit score
- Missing certificates
- Eligibility blockers
- Bid / No-Bid recommendation